Your browser doesn't support javascript.
loading
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Cortellini, Alessio; Tabernero, Josep; Mukherjee, Uma; Salazar, Ramon; Sureda, Anna; Maluquer, Clara; Ferrante, Daniela; Bower, Mark; Sharkey, Rachel; Mirallas, Oriol; Plaja, Andrea; Cucurull, Marc; Mesia, Ricard; Dalla Pria, Alessia; Newsom-Davis, Thomas; Van Hemelrijck, Mieke; Sita-Lumsden, Ailsa; Apthorp, Eleanor; Vincenzi, Bruno; Di Fazio, Giuseppina Rita; Tonini, Giuseppe; Pantano, Francesco; Bertuzzi, Alexia; Rossi, Sabrina; Brunet, Joan; Lambertini, Matteo; Pedrazzoli, Paolo; Biello, Federica; D'Avanzo, Francesca; Lee, Alvin J X; Shawe-Taylor, Marianne; Rogers, Lucy; Murphy, Cian; Cooper, Lee; Andaleeb, Ramis; Khalique, Saira; Bawany, Samira; Ahmed, Sarah; Carmona-García, M Carmen; Fort-Culillas, Roser; Liñan, Raquel; Zoratto, Federica; Rizzo, Gianpiero; Perachino, Marta; Doonga, Kris; Gaidano, Gianluca; Bruna, Riccardo; Patriarca, Andrea; Martinez-Vila, Clara; Pérez Criado, Ignacio.
  • Cortellini A; Department of Surgery and Cancer, Imperial College London, London, UK; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy. Electronic address: a.cortellini@imperial.ac.uk.
  • Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain.
  • Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK.
  • Salazar R; Catalan Institute of Oncology (ICO), University of Barcelona, Bellvitge Biomedical Research Institute (IDIBELL), CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Maluquer C; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Ferrante D; Unit of Medical Statistics, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Mirallas O; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, IOB-Quiron, UVic-UCC, Barcelona, Spain.
  • Plaja A; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology, Badalona, Spain.
  • Cucurull M; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology, Badalona, Spain.
  • Mesia R; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology, Badalona, Spain.
  • Dalla Pria A; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Apthorp E; Medical School, King's College London, London, UK.
  • Vincenzi B; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy.
  • Di Fazio GR; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy.
  • Tonini G; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy.
  • Pantano F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128 Roma, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21 - 00128 Roma, Italy.
  • Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Lambertini M; Medical Oncology Department, UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy.
  • Pedrazzoli P; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy.
  • D'Avanzo F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy.
  • Lee AJX; Cancer Division, University College London Hospitals, London, UK.
  • Shawe-Taylor M; Cancer Division, University College London Hospitals, London, UK.
  • Rogers L; Cancer Division, University College London Hospitals, London, UK.
  • Murphy C; Cancer Division, University College London Hospitals, London, UK.
  • Cooper L; Cancer Division, University College London Hospitals, London, UK.
  • Andaleeb R; Cancer Division, University College London Hospitals, London, UK.
  • Khalique S; Cancer Division, University College London Hospitals, London, UK.
  • Bawany S; Cancer Division, University College London Hospitals, London, UK.
  • Ahmed S; Cancer Division, University College London Hospitals, London, UK.
  • Carmona-García MC; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Fort-Culillas R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Liñan R; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Perachino M; Medical Oncology Department, UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Genova, Italy.
  • Doonga K; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy.
  • Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy.
  • Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Ospedale Maggiore della Caritá, Novara, Italy.
  • Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain.
  • Pérez Criado I; Fundació Althaia Manresa, Manresa, Spain.
Lancet Oncol ; 24(4): 335-346, 2023 04.
Article en En | MEDLINE | ID: mdl-36898391
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article